Intraoperative Biomechanics in Complex Abdominal Wall Reconstruction
NCT ID: NCT03296475
Last Updated: 2018-05-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
20 participants
INTERVENTIONAL
2018-01-09
2021-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Method: An in depth biomechanical and physiological study of 18-22 participants with midline ventral hernias will be carried out. Ventral hernias at least 5cm in width and only those in which primary fascial closure have been achieved will be included. Any operative technique used to achieve primary fascial closure will be included. Biomechanical and physiological measurements will be taken at five separate stages during the course of the patients' abdominal wall reconstruction. The final lung function tests, taken six weeks post op, will be compared to the patients' pre-operative tests. Meticulous attention will be paid to the study protocol making sure that in each patient the measurements are all taken at the same time and under the same conditions.
Discussion: This full biomechanical and physiological work up will enable AWR surgeons to assess when an AWR patient is subjected to too much biomechanical and physiological stress. The abdominal wall tension and strain will be measured to see if this predicts post complications and hernia recurrence.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Midline Ventral Hernia
Main inclusion criteria:
* Patients with midline hernia defects.
* Patients with either a maximal ventral hernia axial width of greater than 5cm or a loss of domain of greater then 20%.
* Patients aged ≥ 18 years old.
* Midline hernias closed in the midline with primary fascial closure with or without mesh augmentation.
* Midline ventral hernias of VHWG grade 2 or 3.
Abdominal Wall Closure Force (N).
This measurement will be recorded for both the right and left anterior rectus sheath. We will measure this force at three anatomical points 1) at the level of the umbilicus and 2) at the halfway point between the pubic symphysis and the xiphisternum and 3) at the point of maximal hernia defect width.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Abdominal Wall Closure Force (N).
This measurement will be recorded for both the right and left anterior rectus sheath. We will measure this force at three anatomical points 1) at the level of the umbilicus and 2) at the halfway point between the pubic symphysis and the xiphisternum and 3) at the point of maximal hernia defect width.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients undergoing primary or incisional ventral hernia repair, without formation of or closure of a stoma.
* Patients with either a maximal ventral hernia axial width of greater than 5cm or a loss of domain of greater then 20%, as measured on their pre-operative CT or MRI scan. The loss of domain will be measured using the patients' preoperative CT or MRI scan following the method of Tanaka et al.
* Patients aged ≥ 18 years old.
* Midline hernias closed in the midline with primary fascial closure with or without mesh augmentation. Any reconstruction technique can be used (e.g. anterior or posterior component separation) as long as primary fascial closure is achieved. The mesh may be placed in either the retro-rectus position (with or without a transverse abdominis release) or the onlay position.
* Participants who have a synthetic or bio-synthetic mesh implanted.
* Midline ventral hernias of VHWG grade 2 or 3. Clean and or Clean-contaminated wound classification.
* The participant is legally competent, has been informed of the nature, the scope and the relevance of the study, voluntarily agrees to take part and has duly signed the consent form.
Exclusion Criteria
* Defects not in the midline. Patients with one or more defect not through the linea alba on the pre-operative CT scan.
* AWR for abdominal wall sarcoma, invasive intra-abdominal carcinoma or other malignant disease.
* Contaminated VHWG grade 4 hernias. Or Contaminated or Dirty wound according to the CDC wound classification system.
* Concomitant procedures such as bowel resection.
* The hernia requires a bridged repair.
* Individuals with co-morbid respiratory disease requiring oral corticosteroids or home oxygen therapy.
* Individuals who require the mesh to be placed in the intra-abdominal position.
* A patient with active peritonitis or an active mesh or subcutaneous infection.
* Individuals with a diagnosis of Crohn's disease.
* Individuals of American Society of Anesthesiology grade 4 or 5.
* Complete removal of an existing synthetic mesh (or biosynthetic mesh if not absorb) from a prior hernia repair in the same location is not possible.
* Participants with human immunodeficiency virus (HIV), known liver cirrhosis or alcohol abuse with a known relapse within 12 months.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University College London Hospitals
OTHER
University College, London
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Suzanne Emerton, BA
Role: STUDY_DIRECTOR
Joint Research Office, University College London
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Univeristy College London
London, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
17/0344
Identifier Type: -
Identifier Source: org_study_id